Fuentes, Nancy .
HRN: 22-43-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/05/2023
01/11/2023
IV
1vial
Q6H
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes